ALYSSA MARTINEZ: Open Payments
NPI 1972376960 · MANAHAWKIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 17 payments from 9 companies in 2025. Trend: 2023 $142 · 2024 $283 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $131 |
| TAIHO ONCOLOGY, INC. | 3 | $63 |
| SOBI, INC | 3 | $60 |
| Novartis Pharmaceuticals Corporation | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Adaptive Biotechnologies Corporation | 1 | $26 |
| Lilly USA, LLC | 1 | $18 |
| Geron Corporation | 1 | $17 |
| Incyte Corporation | 1 | $16 |
Products named: LONSURF, PLUVICTO, Doptelet, clonoSEQ, ENHERTU, VERZENIO, IMFINZI, RYTELO.
Industry payments across NJ — which companies pay providers there.
